Dow Dips Over 250 Points Following Jobs Data: Investor Sentiment Weakens, Greed Index Remains In ‘Fear’ Zone
U.S. stocks fell as strong jobs data boosted Fed rate-hike odds. Fear & Greed Index declined to 41.9, while LULU and GWRE dropped.
Stocks · News reference
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday
Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s earnings expected.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
ABM Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
ABM Industries is expected to post Q3 EPS of $1.01 and revenue of $2.32B, while analysts largely maintain Neutral or Hold ratings.
Ahead of ABM Industries (ABM) Q3 Earnings: Get Ready With Wall Street Estimates for Key Metrics
Wall Street analysts expect ABM Industries to report Q3 earnings of $1.01 per share, representing a 23.2% year-over-year increase, with revenues projected at $2.3 billion, up 3.5% from the prior year. The company carries a Zacks Rank #3 (Hold) rating, suggesting performance aligned with the overall market. No revisions to consensus EPS estimates have occurred over the past 30 days.
Stock Market Today: S&P 500, Dow Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction — ASML, NVS, CASY in Focus
Stock Market Today: S&P 500, Dow Futures Fall as Oil Tops $99 Despite Trump’s Price Drop Prediction— ASML, NVS, CASY in Focus
Stock Market: Will S&P 500 Open Up or Down Today?
Will the S&P 500 open higher? Polymarket odds plunge to 28% as Wall Street faces a historic post-Labor Day slump and surging oil prices.
Co-Diagnostics CFO Brian Brown Departs Company; Appoints Daniel Bohrer As Principal Financial Officer, Effective September 2, 2026
On September 2, 2026, Co-Diagnostics, Inc. (the "Company") and Brian Brown, the Company’s Chief Financial Officer, determined that Mr. Brown’s last day of employment with the Company would be September 2, 2026